Incontinence and Ostomy Care Products Market Overview

Valued at USD 16.99 billion in 2024, the incontinence and ostomy care products market is projected to reach USD 17.88 billion in 2025 and USD 28.53 billion by 2034, growing at a CAGR of 5.33% during the forecast period 2025–2034. The market covers medical devices and supplies designed to manage urinary or fecal incontinence and to support patients with ostomies following surgical procedures. Key players include B. Braun SE; BD (Becton Dickinson); Byram Healthcare Centers, Inc; CliniMed Limited; Coloplast Corp (SenSura, Assura brands); Convatec Group PLC; Essity; Hollister Incorporated; Salts Healthcare; and Welland Medical Ltd. Historical data covers 2020–2023, and North America was the largest regional market in 2024.

Incontinence Care Products Dominate Revenue

By type, the market is segmented into incontinence care products and ostomy care products. Incontinence care products accounted for a 75.0% revenue share in 2024. The dominance reflects widespread usage across a broad patient demographic, including the elderly, post-surgical patients, and individuals with mobility issues or chronic conditions. These products are used in both institutional and home healthcare environments and provide daily support for urinary and fecal incontinence. Absorbents such as pads, adult diapers, and protective garments form a diverse product range, and the discreet design and improved comfort of modern products have made them more acceptable, encouraging greater adoption. The segment also includes incontinence bags and other products.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/incontinence-and-ostomy-care-products-market

Ostomy Care Products Post the Fastest Growth

Ostomy care products are expected to witness the fastest growth during the forecast period. Growth is driven by the increasing prevalence of colorectal cancer, inflammatory bowel disease, and other gastrointestinal disorders requiring surgical intervention. Awareness of post-surgical care and the availability of advanced solutions are boosting adoption among patients and providers. The ostomy segment spans ostomy bags, including colostomy bags, ileostomy bags, and urostomy bags with continent ileostomy and continent urostomy variants, as well as deodorants, skin barriers, and irrigation products. Continuous improvements in design, such as skin-friendly adhesives, odor control systems, and discreet wearables, enhance comfort and confidence. In February 2024, Convatec launched Esteem Body with Leak Defense, a one-piece convex ostomy system whose portfolio includes drainable, closed-end, and urostomy options designed to fit diverse body types and stoma shapes.

Regional Leadership in the Incontinence and Ostomy Care Products Market

North America accounted for the largest global share in 2024, attributed to advanced healthcare infrastructure, high awareness, strong presence of major industry players, robust reimbursement frameworks, and early adoption of innovative solutions. The U.S. held the largest share within the region thanks to its well-established healthcare system, strong consumer access to advanced products, and widespread insurance coverage. Asia Pacific is projected to grow fastest from 2025 to 2034, driven by an expanding aging population, growing awareness of hygiene, and rising healthcare expenditure. India's total health expenditure for fiscal year 2022 was estimated at USD 108.5 billion, representing 3.8% of GDP and roughly USD 79 per capita.

Europe and the UK

Europe is projected to hold a substantial share by 2034, supported by an aging population, strong public health policies, and widespread institutional care infrastructure. In the UK, the NHS and other providers actively promote high-quality, cost-effective solutions, and the focus on home-based healthcare has accelerated uptake.

Industry Developments and Constraints

In May 2025, Kimberly-Clark announced a more than USD 2 billion investment over five years to expand North American operations for absorbent hygiene products such as Depend. In May 2024, Coloplast enhanced its Luja catheter line, using 28% less plastic and delivering a 22% lower carbon footprint than previous models. High product costs and limited reimbursement in developing markets continue to restrict accessibility, even as awareness of skin-friendly products in emerging economies presents untapped potential.

Strategic Outlook

With a 5.33% CAGR projected through 2034, stakeholders should balance incontinence and ostomy care products volume leadership with ostomy innovation and Asia Pacific expansion. Asia Pacific and India offer particular headroom as healthcare access improves.

More Trending Latest Reports By Polaris Market Research:

green-hydrogen-market

coolant-distribution-unit-market

music-streaming-market

air-purifier-market

lithium-carbonate-market

australia-bubble-tea-market

high-speed-camera-market

hydrocolloids-market

smart-sports-equipment-market